| Serial Number | 79091998 |
| Word Mark | ACLARUSDX |
| Filing Date | Tuesday, August 24, 2010 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Monday, August 24, 2020 |
| Registration Number | 4024702 |
| Registration Date | Tuesday, September 13, 2011 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, June 28, 2011 |
| Indication of Colors claimed | The color(s) red and blue is/are claimed as a feature of the mark. |
| Description of Mark | The mark consists of the wording "ACLARUSDX", with "ACLARUS" in blue and "DX" in red". |
| Goods and Services | Chemical preparations and compositions, namely, nucleic acids attached to a solid medium, for industrial and scientific use; chemical fissile preparations for laboratory use; chemical fissile preparations for scientific research; chemical preparations for nucleic acids attached to a solid medium, other than for medical or veterinary purposes; biological preparations, other than for medical or veterinary purposes, namely, blood for enabling the quantification of nucleic acid content; chemicals for scientific use, other than for medical or veterinary purposes; chemical preparations or reagents for laboratory, namely, nucleic acid to screen and analyze gene expression, to identify therapeutic targets and products, and to conduct pharmacogenomic and genotoxicity research in the fields of pharmacology, food, chemistry, cosmetology, plant protection, and veterinary sciences; chemical preparations for scientific use, namely, nucleic acid libraries to screen and analyze gene expression, to identify therapeutic targets and products, and to conduct pharmacogenomic and genotoxicity research in the fields of pharmacology, food, chemistry, cosmetology, plant protection, and veterinary sciences; chemical preparations for scientific use, namely, DNA biochips for decoding genes affected by the Alzheimer's disease or revealing the transcriptomic signature of patients affected with Alzheimer's disease, and DNA chips to make visible and analyze gene expression in the fields of human and pharmacological medicine and veterinary science |
| Goods and Services | Pharmaceutical preparations for treating neurodegenerative diseases, particularly Alzheimer's disease; diagnostic reagents and media for medical use, namely, reagents and media for use in testing blood biomarkers, to enable the identification of patients suffering from Alzheimer's disease or at risk of developing the disease and for enabling the identification of patients responding to specific treatments; acidic biological preparations and products for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing Alzheimer's disease; capsules for diagnostic tests and medicines sold empty; chemico-pharmaceutical preparations for diagnosing, preventing and treating Alzheimer's disease; biopharmaceutical preparations for diagnosing, preventing and treating Alzheimer's disease; chemicals for medical, pharmaceutical or veterinary purposes, namely, chemicals for diagnosing neurodegenerative diseases, especially Alzheimer's disease; medical and clinical diagnosis testing kits comprised of nucleic acid banks, nucleic acids on DNA chips and testing probes; DNA libraries and RNA libraries for medical diagnostic purposes; nucleic acid sequences for use on biochips, for medical and medical diagnostic use, namely, for decoding genes affected by Alzheimer's disease or revealing the transcriptomic signature of patients suffering from Alzheimer's disease; enzymes or enzyme preparations for medical or veterinary purposes, namely, enzyme stabilizers and enzyme substrates used as ingredients in medicines for treatment of Alzheimer's disease; reagents contained in diagnostic test kits for taking blood samples, for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions |
| Goods and Services | Surgical, medical, dental and veterinary apparatus and instruments, namely, apparatus and instruments for use in identifying, assessing the seriousness of, assessing the prognoses of, measuring the progression of and measuring the conversion of neurodegenerative diseases such as Alzheimer's; medical apparatus using DNA chips for analyzing blood; apparatus for analyzing blood; apparatus for medical diagnostic purposes, namely, kits for taking blood samples comprising medical instruments for taking blood, DNA chips for diagnosing Alzheimer's disease, and material required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions; spoons for medicines; containers specially adapted for the application of medicines, namely, bags and pouches used in the delivery of medication; probes for medical purposes; syringes for medical purposes; galvanic therapeutic devices for diagnosing neurodegenerative diseases, especially Alzheimer's disease |
| Goods and Services | Research and development for others of pharmaceutical molecules or biological markers and medicines for diagnosing and treating neurodegenerative diseases; chemical analyses; chemical research; chemical services, namely, analysis of RNA genes, tissues, and blood samples; biotechnological project studies to identify people suffering from Alzheimer's disease and to measure the seriousness, prognoses, progression and conversion of the disease and to determine how patients respond to treatments; research and development of new products for others; biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analyses, namely, quantification of nucleic acid content for medical and scientific research purposes |
| Goods and Services | Medical services; veterinary services; medical assistance; consulting in the fields of biotechnology and pharmacy, namely, to assist in the selection of Alzheimer's sufferers for clinical trials and to offer personalized treatments; hospitals; pharmacist's services to make up prescriptions; pharmaceutical advice; medical services, namely, facilitating the diagnosis and care of geriatric patients and patients with neurodegenerative diseases; health care; telemedicine services |
| Pseudo Mark | ACLARUS DX |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 1 - Sec. 7(d) - Entire Registration |
| Class Status Date | Friday, December 5, 2014 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 1 - Sec. 7(d) - Entire Registration |
| Class Status Date | Friday, December 5, 2014 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 1 - Sec. 7(d) - Entire Registration |
| Class Status Date | Friday, December 5, 2014 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 1 - Sec. 7(d) - Entire Registration |
| Class Status Date | Friday, December 5, 2014 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 1 - Sec. 7(d) - Entire Registration |
| Class Status Date | Friday, December 5, 2014 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EXONHIT S.A. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Party Name | ExonHit Therapeutics |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | F-75013 Paris FR |
| Party Name | ExonHit Therapeutics |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | F-75013 Paris FR |
| Event Date | Event Description |
| Friday, September 10, 2021 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Friday, September 10, 2021 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, September 25, 2015 | TOTAL INVALIDATION PROCESSED BY THE IB |
| Wednesday, September 2, 2015 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Wednesday, September 2, 2015 | INVALIDATION PROCESSED |
| Wednesday, August 5, 2015 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Friday, December 5, 2014 | CANCELLED SECTION 7-TOTAL |
| Friday, December 5, 2014 | CANCELLATION TERMINATED NO. 999999 |
| Wednesday, December 3, 2014 | CANCELLATION DENIED NO. 999999 |
| Friday, October 24, 2014 | CANCELLATION INSTITUTED NO. 999999 |
| Sunday, May 19, 2013 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, December 23, 2011 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, December 23, 2011 | FINAL DISPOSITION PROCESSED |
| Tuesday, December 13, 2011 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Saturday, October 15, 2011 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Tuesday, September 13, 2011 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 28, 2011 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 28, 2011 | PUBLISHED FOR OPPOSITION |
| Thursday, May 26, 2011 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, May 26, 2011 | ASSIGNED TO LIE |
| Thursday, May 12, 2011 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, May 12, 2011 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, May 12, 2011 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 12, 2011 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 12, 2011 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, April 26, 2011 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, April 26, 2011 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 26, 2011 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 26, 2011 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, February 27, 2011 | REFUSAL PROCESSED BY IB |
| Wednesday, February 9, 2011 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, February 9, 2011 | REFUSAL PROCESSED BY MPU |
| Wednesday, February 9, 2011 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, February 8, 2011 | NON-FINAL ACTION WRITTEN |
| Tuesday, February 8, 2011 | APPLICATION FILING RECEIPT MAILED |
| Friday, February 4, 2011 | ASSIGNED TO EXAMINER |
| Friday, February 4, 2011 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, February 3, 2011 | SN ASSIGNED FOR SECT 66A APPL FROM IB |